Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 70

Results For "ECR"

734 News Found

Brinton launches Hohner Health in India
Healthcare | September 06, 2021

Brinton launches Hohner Health in India

The focus is on wellness and personal care products


Indigenous technology will help reduce dependence on imports: Dr Singh
Digitisation | September 03, 2021

Indigenous technology will help reduce dependence on imports: Dr Singh

Union Minister addresses the 13th CII Global MedTech Summit on the sunrise medical devices sector in India


Digital adoption in healthcare will see exponential growth: Wipro GE study
Healthcare | September 03, 2021

Digital adoption in healthcare will see exponential growth: Wipro GE study

Key trends indicate that AI-based solutions, cloud-based healthcare solutions and digital transformations will be the key in the years to come.


Union Minister Mansukh Mandaviya chairs meet on eradicating TB
Policy | September 02, 2021

Union Minister Mansukh Mandaviya chairs meet on eradicating TB

Coordinated and collaborative efforts will strongly contribute to the achievement of shared goals faster: Mandaviya


Ami Organics bets on strategic acquisitions as its IPO opens on Sept 1
News | September 01, 2021

Ami Organics bets on strategic acquisitions as its IPO opens on Sept 1

The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio


Sher-I-Kashmir Institute of Medical Sciences and Medtronic partner to open Surgical Skills Lab
Digitisation | September 01, 2021

Sher-I-Kashmir Institute of Medical Sciences and Medtronic partner to open Surgical Skills Lab

The lab has been developed to aid surgeons to overcome the challenging learning curve to obtain laparoscopic expertise


South Asia’s first advanced Genomics Research Centre open in Hyderabad
Biotech | August 28, 2021

South Asia’s first advanced Genomics Research Centre open in Hyderabad

The centre established by Nucleome Informatics will take up the sequencing of 5,000 Covid genomes and 500 human genomes in the coming months


Japan approves AstraZeneca’s Forxiga for chronic kidney disease
Drug Approval | August 28, 2021

Japan approves AstraZeneca’s Forxiga for chronic kidney disease

Over 13 million people in Japan suffer from chronic kidney disease and this will transform treatment options


Johnson & Johnson booster dose indicate impressive results
Drug Approval | August 26, 2021

Johnson & Johnson booster dose indicate impressive results

New interim data from these studies demonstrate that a booster dose of the Johnson & Johnson Covid-19 vaccine generated a rapid and robust increase in spike-binding antibodies, nine-fold higher than 28 days after the primary single-dose vaccination.


RedHill Biopharma's Opaganib demonstrates strong inhibition of COVID-19 Delta variant
Drug Approval | August 26, 2021

RedHill Biopharma's Opaganib demonstrates strong inhibition of COVID-19 Delta variant

Opaganib, a leading novel small molecule investigational oral pill in development for Covid-19, is a unique host targeted, dual antiviral and anti-inflammatory drug that acts on the cause and effect of the disease